Gastric Adenocarcinoma Outcome

What is the Purpose of this Study?

Our primary outcome will be overall survival at 1 year with secondary outcomes being disease-free survival at 1, 3, and 5 years. We will also be looking at overall survival at these time points.


Eligibility

Not Available


Where can I participate?

Beverly


What is the full name of this clinical trial?

Retrospective Review: Signet Ring Cell Histologic Subtype in Gastric Adenocarcinoma: Survival and Prognosis

Study Details
Disease Type/Condition

Other

Principal Investigator

Burch, Miguel

Age Group

Adult

Phase

N/A

IRB Number

STUDY00000668


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Burch, Miguel

Age Group

Adult

Phase

N/A

IRB Number

IIT-2020-02-BURCH-GASTRICCA


Contact
Email
clinicaltrials@cshs.org